Gennady Efimovich Gendlin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gennady Efimovich Gendlin has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Igor Gennadievich Nikitin
N.I. Pirogov Russian National Research Medical University
14 shared publications - Elena I. Emelina
РНИМУ им. Н.И. Пирогова
7 shared publications - Azamat Maratovich Baymukanov
Buyanov City Clinical Hospital
5 shared publications - Irina V. Kovtyukh
The Russian National Research Medical University named after N.I. Pirogov
5 shared publications G I Storozhakov
4 shared publications- Svetlana N. Dvornikova
Petrovsky Russian Scientific Center of Surgery, Moscow
3 shared publications
Latest Publications
- 26 December 2025
- Published by Russian Dialysis Society in Nephrology and Dialysis
- Vol. 27 (4)
Phenotype of patients receiving renal replacement therapy with programmed hemodialysis and who died suddenly during the interdialytic period
Introduction . Kidney replacement therapy – primarily maintenance hemodialysis (MHD) – has enabled patients with end-stage kidney disease to survive for decades despite the loss of kidney function. Consequently, mortality in this population is now largely driven by other causes, including cardiovascular disease, infections, including sepsis, and cancer. Risk factors for with sudden cardiac death (SCD) in patients receiving MHD only partially overlap with those in the general population: renal failure and hemodialysis significantly increase the risk of SCD compared with individuals who have preserved renal function. The aim of our study was to identify a possible predictor phenotype for SCD in patients undergoing MHD. We analyzed the impact of echocardiographic (EchoCG), electrocardiographic (ECG), and laboratory parameters on overall and cardiac five-year survival in prospective single center patients cohort (n=212) undergoing MHD from 2001 till 2025. Results : data from 14 deceased patients (31.1% of all cardiac deaths) met the criteria for non-dialytic SCD. We identified clinical profile characteristics of patients who experienced SCD during long-term MHD. The only echocardiographic parameter at baseline differed significantly in the SCD group was the end-diastolic volume (EDV). The median EDV in patients with SCD, regardless of left ventricle ejection fraction (LVEF), was markedly higher than in patients in other groups: 182.8 (144.9-226.2) ml in the SCD group ( n =14), 101.0 (75.0-129.3) ml in the reduced LVEF group ( n =52), 104.1 (101.2-167.0) ml in the other causes group ( n =45), and 114.2 (81.7-140.5) ml in currently living patients ( n =99, р =0.007). Compared with patients who died from other causes, those with SCD were younger, had LV dilation, and a relatively short dialysis vintage. Survival was particularly poor in SCD patients with LVEF Conclusion : the results of this study indicate that patients younger than 55 years, with a with a relatively short dialysis history and left ventricular dilation, especially when LVEF is reduced, carry a higher risk of SCD on MHD.
- 26 December 2025
- Published by Russian Dialysis Society in Nephrology and Dialysis
- Vol. 27 (4)
Phenotype of patients receiving renal replacement therapy with programmed hemodialysis and who died suddenly during the interdialytic period
Introduction . Kidney replacement therapy – primarily maintenance hemodialysis (MHD) – has enabled patients with end-stage kidney disease to survive for decades despite the loss of kidney function. Consequently, mortality in this population is now largely driven by other causes, including cardiovascular disease, infections, including sepsis, and cancer. Risk factors for with sudden cardiac death (SCD) in patients receiving MHD only partially overlap with those in the general population: renal failure and hemodialysis significantly increase the risk of SCD compared with individuals who have preserved renal function. The aim of our study was to identify a possible predictor phenotype for SCD in patients undergoing MHD. We analyzed the impact of echocardiographic (EchoCG), electrocardiographic (ECG), and laboratory parameters on overall and cardiac five-year survival in prospective single center patients cohort (n=212) undergoing MHD from 2001 till 2025. Results : data from 14 deceased patients (31.1% of all cardiac deaths) met the criteria for non-dialytic SCD. We identified clinical profile characteristics of patients who experienced SCD during long-term MHD. The only echocardiographic parameter at baseline differed significantly in the SCD group was the end-diastolic volume (EDV). The median EDV in patients with SCD, regardless of left ventricle ejection fraction (LVEF), was markedly higher than in patients in other groups: 182.8 (144.9-226.2) ml in the SCD group ( n =14), 101.0 (75.0-129.3) ml in the reduced LVEF group ( n =52), 104.1 (101.2-167.0) ml in the other causes group ( n =45), and 114.2 (81.7-140.5) ml in currently living patients ( n =99, р =0.007). Compared with patients who died from other causes, those with SCD were younger, had LV dilation, and a relatively short dialysis vintage. Survival was particularly poor in SCD patients with LVEF Conclusion : the results of this study indicate that patients younger than 55 years, with a with a relatively short dialysis history and left ventricular dilation, especially when LVEF is reduced, carry a higher risk of SCD on MHD.
- Open Access
- 18 December 2025
- Published by Publishing House ABV Press in The Clinician
- Vol. 19 (3) , 65-72
Training of primary care doctors to perform comprehensive medical services to combat veterans
Currently, comprehensive medical care for combat veterans on the part of primary care doctors is an important problem. To improve the unified teaching strategy in medical universities for preparation of highly qualified specialists, the main questions of the training process of students studying the general medicine specialty are discussed. The article presents points of view of psychiatrists, psychologists, internal medicine doctors, ophthalmologists, dermatologists, and proposals on optimization of continuity of teaching how to manage patients with post-traumatic stress disorder and how to improve communication skills of future doctors during caring for patients with this acute emotional disorder. To improve preparedness of medical students to apply knowledge in clinical practice, the experts focus on the classical manifestations of post-traumatic stress disorder and psychosomatic disorders, teaching systemic approach to patients’ needs with focus on communication during outpatient appointments, discussion of combat stress target organs. During comprehensive discussion, the experts concluded that it is necessary to strengthen interactions between clinical and scientific departments of medical universities to study the role of stress in stepwise development of long-term consequences of stress-induced somatic pathology, to increase attention to details in communication between doctors and patients with post-traumatic stress disorder, to introduce problems of outpatient observation of combat veterans into the summer working practice of 5th year students training in general medicine. Regular updates of the training materials will help to better understand the problem of post-traumatic stress disorder and prepare graduates for performing qualified and rounded medical services to combat veterans.
- 18 December 2025
- Published by Publishing House ABV Press in The Clinician
- Vol. 19 (3) , 65-72
Open AccessTraining of primary care doctors to perform comprehensive medical services to combat veterans
Currently, comprehensive medical care for combat veterans on the part of primary care doctors is an important problem. To improve the unified teaching strategy in medical universities for preparation of highly qualified specialists, the main questions of the training process of students studying the general medicine specialty are discussed. The article presents points of view of psychiatrists, psychologists, internal medicine doctors, ophthalmologists, dermatologists, and proposals on optimization of continuity of teaching how to manage patients with post-traumatic stress disorder and how to improve communication skills of future doctors during caring for patients with this acute emotional disorder. To improve preparedness of medical students to apply knowledge in clinical practice, the experts focus on the classical manifestations of post-traumatic stress disorder and psychosomatic disorders, teaching systemic approach to patients’ needs with focus on communication during outpatient appointments, discussion of combat stress target organs. During comprehensive discussion, the experts concluded that it is necessary to strengthen interactions between clinical and scientific departments of medical universities to study the role of stress in stepwise development of long-term consequences of stress-induced somatic pathology, to increase attention to details in communication between doctors and patients with post-traumatic stress disorder, to introduce problems of outpatient observation of combat veterans into the summer working practice of 5th year students training in general medicine. Regular updates of the training materials will help to better understand the problem of post-traumatic stress disorder and prepare graduates for performing qualified and rounded medical services to combat veterans.
- Open Access
- 23 September 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (5) , 483-492
Deterioration of chronic heart failure due to lead-associated tricuspid regurgitation: a review
Implantable intracardiac devices, including permanent pacemakers, cardioverter-defibrillators, and cardiac resynchronization therapy systems, have become firmly established in clinical practice and demonstrated efficacy in improving prognosis in patients with bradyarrhythmias, high risk of sudden cardiac death, and chronic heart failure. However, with the increasing number of implantations, late complications are attracting more attention, particularly tricuspid regurgitation associated with implanted intracardiac leads. It has been shown that lead-associated tricuspid regurgitation may be linked to worsening heart failure symptoms, increased hospitalization rates, and reduced survival. Nevertheless, the pathophysiologic mechanisms of this condition, its clinical course, and diagnostic approaches remain insufficiently standardized, and current clinical guidelines lack clear management algorithms. According to published data, the prevalence of tricuspid regurgitation after lead implantation ranges from 7% to 39%, reflecting heterogeneity across reports and the absence of unified diagnostic criteria. This considerably complicates assessment of the true prevalence and clinical significance of this complication. An additional challenge is the choice of treatment strategy, especially when deciding on transvenous lead extraction or surgical correction. Thus, an individualized and multidisciplinary approach is required for each patient, and further investigations are needed to develop consistent clinical recommendations.
- 23 September 2025
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 31 (5) , 483-492
Open AccessDeterioration of chronic heart failure due to lead-associated tricuspid regurgitation: a review
Implantable intracardiac devices, including permanent pacemakers, cardioverter-defibrillators, and cardiac resynchronization therapy systems, have become firmly established in clinical practice and demonstrated efficacy in improving prognosis in patients with bradyarrhythmias, high risk of sudden cardiac death, and chronic heart failure. However, with the increasing number of implantations, late complications are attracting more attention, particularly tricuspid regurgitation associated with implanted intracardiac leads. It has been shown that lead-associated tricuspid regurgitation may be linked to worsening heart failure symptoms, increased hospitalization rates, and reduced survival. Nevertheless, the pathophysiologic mechanisms of this condition, its clinical course, and diagnostic approaches remain insufficiently standardized, and current clinical guidelines lack clear management algorithms. According to published data, the prevalence of tricuspid regurgitation after lead implantation ranges from 7% to 39%, reflecting heterogeneity across reports and the absence of unified diagnostic criteria. This considerably complicates assessment of the true prevalence and clinical significance of this complication. An additional challenge is the choice of treatment strategy, especially when deciding on transvenous lead extraction or surgical correction. Thus, an individualized and multidisciplinary approach is required for each patient, and further investigations are needed to develop consistent clinical recommendations.
- Open Access
- 8 March 2025
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 32 (1) , 6-14
Clinical significance of premature atrial contractions and approaches to its treatment
Supraventricular premature beats (PACs) are common in the general population. Previously considered a benign ECG finding with little clinical significance. However, increasing evidence now suggests a positive correlation between the frequency of PACs and the risk of developing atrial fibrillation, ischemic stroke, transient ischemic attack, and all-cause mortality. This has highlighted the importance of determining the clinical significance of PACs and the management strategies for affected patients.
- 8 March 2025
- Published by Institute of Cardio Technics - INCART in Journal of Arrhythmology
- Vol. 32 (1) , 6-14
Open AccessClinical significance of premature atrial contractions and approaches to its treatment
Supraventricular premature beats (PACs) are common in the general population. Previously considered a benign ECG finding with little clinical significance. However, increasing evidence now suggests a positive correlation between the frequency of PACs and the risk of developing atrial fibrillation, ischemic stroke, transient ischemic attack, and all-cause mortality. This has highlighted the importance of determining the clinical significance of PACs and the management strategies for affected patients.
- Open Access
- 31 August 2024
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 64 (8) , 64-67
Editorial on the article «Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation»
In relation with the published article "Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation", we have issued a comment. The authors of the article addressed a widely discussed topic of "Short episodes of fast arrhythmias initially detected in records on implantable devices". Further, these episodes are studied already by Holter monitoring of different durations with assessment of their clinical significance. This is the subject of the cited article and our comment.
- 31 August 2024
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 64 (8) , 64-67
Open AccessEditorial on the article «Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation»
In relation with the published article "Natriuretic Peptide Concentrations and Echocardiography Findings in Patients with Micro-atrial Fibrillation", we have issued a comment. The authors of the article addressed a widely discussed topic of "Short episodes of fast arrhythmias initially detected in records on implantable devices". Further, these episodes are studied already by Holter monitoring of different durations with assessment of their clinical significance. This is the subject of the cited article and our comment.
- Open Access
- 5 September 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (7) , 3685
Guidance letter for cardiologists of oncology institutions on the prevention of cardiovascular complications of anticancer therapy. Interdisciplinary Council of Cardio-Oncology, Russian Society of Cardiology
Методическое письмо для кардиологов учреждений онкологического профиля по профилактике сердечно-сосудистых осложнений противоопухолевой терапии. Междисциплинарный совет по кардиоонкологии, Российское кардиологическое общество
- 5 September 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (7) , 3685
Open AccessGuidance letter for cardiologists of oncology institutions on the prevention of cardiovascular complications of anticancer therapy. Interdisciplinary Council of Cardio-Oncology, Russian Society of Cardiology
Методическое письмо для кардиологов учреждений онкологического профиля по профилактике сердечно-сосудистых осложнений противоопухолевой терапии. Междисциплинарный совет по кардиоонкологии, Российское кардиологическое общество
- Open Access
- 5 August 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (7) , 3684
Guidance letter for cardiologists and primary care physicians on primary prevention of cardiovascular complications of anticancer therapy. Interdisciplinary Council of Cardio-Oncology, Russian Society of Cardiology
Методическое письмо для кардиологов и терапевтов первичного звена здравоохранения по первичной профилактике сердечно-сосудистых осложнений противоопухолевой терапии. Междисциплинарный совет по кардиоонкологии, Российское кардиологическое общество
- 5 August 2023
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (7) , 3684
Open AccessGuidance letter for cardiologists and primary care physicians on primary prevention of cardiovascular complications of anticancer therapy. Interdisciplinary Council of Cardio-Oncology, Russian Society of Cardiology
Методическое письмо для кардиологов и терапевтов первичного звена здравоохранения по первичной профилактике сердечно-сосудистых осложнений противоопухолевой терапии. Междисциплинарный совет по кардиоонкологии, Российское кардиологическое общество
- Open Access
- 31 December 2022
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 62 (12) , 30-37
Electrocardiogram QRS Complex Duration as a Predictor of Hospital Prognosis in Patients With COVID-19
Aim To determine the effect of major electrocardiographic (ECG) parameters on the prognosis of patients with COVID-19. Material and methods One of systemic manifestations of COVID-19 is heart injury. ECG is the most simple and available method for diagnosing the heart injury, which influences the therapeutic approach. This study included 174 hospitalized patients with COVID-19. Major ECG parameters recorded on admission and their changes before the discharge from the hospital or death of the patient, were analyzed, and the effect of each parameter on the in-hospital prognosis was determined. Results were compared with the left ventricular ejection fraction (LV EF), laboratory data, and results of multispiral computed tomography (MSCT) of the lungs. Results ECG data differed on admission and their changes differed for deceased and discharged patients. Of special interest was the effect of the QRS complex duration at baseline and at the end of treatment on the in-hospital survival and mortality rate. The Cox regression analysis showed that the QRS complex duration (relative risk (RR) 2.07, 95% confidence interval (CI): 1.17–3.66; р=0.01), MSCT data (RR, 1.54; 95 % CI: 1.14–2.092; р=0.005), and glomerular filtration rate (GFR) (RR, 0.98; 95 % CI: 0.96–0.99; р=0.001) had the highest predictive significance. In further comparison of these three indexes, the QRS duration and GFR retained their predictive significance, and a ROC analysis showed that the cut-off QRS complex duration was 125 ms (р=0.001). Patients who developed left bundle branch block (LBBB) in the course of disease also had an unfavorable prognosis compared to other intraventricular conduction disorders (р=0.038). The presence of LBBB was associated with reduced LV EF (р=0.0078). The presence of atrial fibrillation (AF) significantly predetermines a worse outcome both at the start (р=0.011) and at the end of observation (р=0.034). A higher mortality was observed for the group of deceased patients with ST segment deviations, ST elevation (р=0.0059) and ST depression (р=0.028). Conclusion Thus, the QTc interval elongation, LBBB that developed during the treatment, AF, and increased QRS complex duration are the indicators that determine the in-hospital prognosis of patients with COVID-19. The strongest electrocardiographic predictor for an unfavorable prognosis was the QRS complex duration that allowed stratification of patients to groups of risk.
- 31 December 2022
- Published by APO Society of Specialists in Heart Failure in Kardiologiia
- Vol. 62 (12) , 30-37
Open AccessElectrocardiogram QRS Complex Duration as a Predictor of Hospital Prognosis in Patients With COVID-19
Aim To determine the effect of major electrocardiographic (ECG) parameters on the prognosis of patients with COVID-19. Material and methods One of systemic manifestations of COVID-19 is heart injury. ECG is the most simple and available method for diagnosing the heart injury, which influences the therapeutic approach. This study included 174 hospitalized patients with COVID-19. Major ECG parameters recorded on admission and their changes before the discharge from the hospital or death of the patient, were analyzed, and the effect of each parameter on the in-hospital prognosis was determined. Results were compared with the left ventricular ejection fraction (LV EF), laboratory data, and results of multispiral computed tomography (MSCT) of the lungs. Results ECG data differed on admission and their changes differed for deceased and discharged patients. Of special interest was the effect of the QRS complex duration at baseline and at the end of treatment on the in-hospital survival and mortality rate. The Cox regression analysis showed that the QRS complex duration (relative risk (RR) 2.07, 95% confidence interval (CI): 1.17–3.66; р=0.01), MSCT data (RR, 1.54; 95 % CI: 1.14–2.092; р=0.005), and glomerular filtration rate (GFR) (RR, 0.98; 95 % CI: 0.96–0.99; р=0.001) had the highest predictive significance. In further comparison of these three indexes, the QRS duration and GFR retained their predictive significance, and a ROC analysis showed that the cut-off QRS complex duration was 125 ms (р=0.001). Patients who developed left bundle branch block (LBBB) in the course of disease also had an unfavorable prognosis compared to other intraventricular conduction disorders (р=0.038). The presence of LBBB was associated with reduced LV EF (р=0.0078). The presence of atrial fibrillation (AF) significantly predetermines a worse outcome both at the start (р=0.011) and at the end of observation (р=0.034). A higher mortality was observed for the group of deceased patients with ST segment deviations, ST elevation (р=0.0059) and ST depression (р=0.028). Conclusion Thus, the QTc interval elongation, LBBB that developed during the treatment, AF, and increased QRS complex duration are the indicators that determine the in-hospital prognosis of patients with COVID-19. The strongest electrocardiographic predictor for an unfavorable prognosis was the QRS complex duration that allowed stratification of patients to groups of risk.
- Open Access
- 26 July 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (1) , 47-55
Dynamics of echocardiographic parameters in patients with severe COVID-19 during hospitalization
BACKGROUND: The severe course of a new coronavirus infection may be associated with cardiovascular damage. Thus, there is a need to search for available methods of cardiac status examination to determine management tactics and immediate prognosis in patients with coronavirus disease 2019 (COVID-19). AIM: This study aimed to assess the dynamics of echocardiographic parameters in patients with severe infection during hospitalization. MATERIALS AND METHODS: Forty patients hospitalized for COVID-19 were included in the study. All patients underwent echocardiography on admission to the hospital and in dynamics, that is, upon deterioration of the underlying disease. The ultrasound picture of the heart was compared with the severity of parenchymal damage based on computed tomography (CT) and the degree of respiratory failure based on blood oxygen saturation by pulse oximetry. Concomitant nosologies and autopsy findings were also analyzed. RESULTS: In dynamics, a significant decrease in left ventricular ejection fraction (LVEF) from 47.0% (40.056.0) to 43.5% (37.049.0; p=0.002) was found in the deceased group, which was not observed in the discharged group. Comparative analysis of this index in the discharged and deceased group in study 2 revealed significantly lower values of LVEF in patients with unfavorable hospital prognosis: 51.0% (44.055.0) and 43.5% (37.049.0), respectively (p=0.049). Furthermore, a significantly higher level of systolic pulmonary artery pressure was observed in the deceased group in study 1: 54.0 (50.059.0) and 60.0 (55.570.0) mmHg, respectively (p=0.02), with increasing differences in dynamics, that is, 65.0 (60.070.0) and 50.0 (46.057.0) mmHg, respectively (p 0.0001). Among the indicators reflecting the state of the right ventricle, right ventricular end-systolic size in study 2 in the deceased group (p=0.062) and more pronounced dilatation by this indicator were noted in the group with unfavorable prognosis compared with the discharged group at re-diagnosis (p=0.071). CONCLUSIONS: Dynamic reduction of baseline low LVEF and progression of pulmonary hypertension are the main echocardiographic predictors of hospital mortality in patients with COVID-19. Increased volume of pulmonary parenchyma lesions on CT determines unfavorable hospital prognosis.
- 26 July 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 28 (1) , 47-55
Open AccessDynamics of echocardiographic parameters in patients with severe COVID-19 during hospitalization
BACKGROUND: The severe course of a new coronavirus infection may be associated with cardiovascular damage. Thus, there is a need to search for available methods of cardiac status examination to determine management tactics and immediate prognosis in patients with coronavirus disease 2019 (COVID-19). AIM: This study aimed to assess the dynamics of echocardiographic parameters in patients with severe infection during hospitalization. MATERIALS AND METHODS: Forty patients hospitalized for COVID-19 were included in the study. All patients underwent echocardiography on admission to the hospital and in dynamics, that is, upon deterioration of the underlying disease. The ultrasound picture of the heart was compared with the severity of parenchymal damage based on computed tomography (CT) and the degree of respiratory failure based on blood oxygen saturation by pulse oximetry. Concomitant nosologies and autopsy findings were also analyzed. RESULTS: In dynamics, a significant decrease in left ventricular ejection fraction (LVEF) from 47.0% (40.056.0) to 43.5% (37.049.0; p=0.002) was found in the deceased group, which was not observed in the discharged group. Comparative analysis of this index in the discharged and deceased group in study 2 revealed significantly lower values of LVEF in patients with unfavorable hospital prognosis: 51.0% (44.055.0) and 43.5% (37.049.0), respectively (p=0.049). Furthermore, a significantly higher level of systolic pulmonary artery pressure was observed in the deceased group in study 1: 54.0 (50.059.0) and 60.0 (55.570.0) mmHg, respectively (p=0.02), with increasing differences in dynamics, that is, 65.0 (60.070.0) and 50.0 (46.057.0) mmHg, respectively (p 0.0001). Among the indicators reflecting the state of the right ventricle, right ventricular end-systolic size in study 2 in the deceased group (p=0.062) and more pronounced dilatation by this indicator were noted in the group with unfavorable prognosis compared with the discharged group at re-diagnosis (p=0.071). CONCLUSIONS: Dynamic reduction of baseline low LVEF and progression of pulmonary hypertension are the main echocardiographic predictors of hospital mortality in patients with COVID-19. Increased volume of pulmonary parenchyma lesions on CT determines unfavorable hospital prognosis.
- Open Access
- 19 July 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 27 (6) , 561-569
Blood serum concentration of troponin in patients with COVID-19 of various severities
BACKGROUND: The search for available predictors of hospital survival and mortality rates during the COVID-19 pandemic is an urgent problem. AIM: The study aimed to determine the role of troponin in the immediate prognosis of patients with COVID-19. MATERIALS AND METHODS: The study included 85 patients with a new coronavirus infection upon admission, who underwent a blood test for troponin. All patients underwent an echocardiographic study according to a standard protocol, and the effect of troponin levels on nosocomial survival and mortality rates, correlation of this indicator with the left ventricular ejection fraction, degree of pulmonary hypertension, laboratory parameters, and degree of respiratory failure determined by computed tomography of the lungs and oxygen saturation indicators were analyzed. Correlation analysis with autopsy parameters was performed. RESULTS: A high level of troponin indicated the worst prognosis of patients during hospitalization. The laboratory marker level correlated significantly with the parameters of the left ventricular ejection fraction. Its highest level was determined in patients with type 1 myocardial infarction. Troponin was not correlated with the degree of respiratory failure, as well as the state of the myocardium in the autopsy material. CONCLUSIONS: Determining the troponin levels as a routine laboratory marker can be recommended for stratifying the risk of myocardial damage in patients with COVID-19 during hospitalization.
- 19 July 2022
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 27 (6) , 561-569
Open AccessBlood serum concentration of troponin in patients with COVID-19 of various severities
BACKGROUND: The search for available predictors of hospital survival and mortality rates during the COVID-19 pandemic is an urgent problem. AIM: The study aimed to determine the role of troponin in the immediate prognosis of patients with COVID-19. MATERIALS AND METHODS: The study included 85 patients with a new coronavirus infection upon admission, who underwent a blood test for troponin. All patients underwent an echocardiographic study according to a standard protocol, and the effect of troponin levels on nosocomial survival and mortality rates, correlation of this indicator with the left ventricular ejection fraction, degree of pulmonary hypertension, laboratory parameters, and degree of respiratory failure determined by computed tomography of the lungs and oxygen saturation indicators were analyzed. Correlation analysis with autopsy parameters was performed. RESULTS: A high level of troponin indicated the worst prognosis of patients during hospitalization. The laboratory marker level correlated significantly with the parameters of the left ventricular ejection fraction. Its highest level was determined in patients with type 1 myocardial infarction. Troponin was not correlated with the degree of respiratory failure, as well as the state of the myocardium in the autopsy material. CONCLUSIONS: Determining the troponin levels as a routine laboratory marker can be recommended for stratifying the risk of myocardial damage in patients with COVID-19 during hospitalization.